DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

PTC Industries Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·21 Oct 2026, 8:48 am

PTC Industries

PTC Industries Limited has filed a certificate with stock exchanges to comply with SEBI's Depositories and Participants Regulations, 2018. This regulatory filing confirms the company's adherence to specific rules regarding the maintenance of its securities in depositories. It is a standard procedural update designed to ensure transparency and proper record-keeping of the company's shares.

For investors, this development is largely procedural and does not signal any operational change or financial distress. It serves as a routine compliance measure that maintains the company's standing with regulatory bodies. The move reinforces the company's commitment to corporate governance standards.

Investors should monitor the company's future filings for any material news. As this is a standard regulatory compliance update, it is not expected to impact the stock's price in the short term. Continued focus should remain on the company's core business performance and earnings reports.